The Use of Allopurinol and Benzbromarone for Coronary Artery Disease Prophylaxis in Patients with Gout
碩士 === 臺北醫學大學 === 藥學系(碩博士班) === 102 === Background Coronary artery disease (CAD), caused by narrowing or obstruction of coronary artery, has been recently reported to be associated with gout. However, studies on the preventive effect of urate-lowering agents on CAD are still limited. The present stu...
Main Authors: | Ching-Huan Wang, 王靖寰 |
---|---|
Other Authors: | Li-Hsuan Wang |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/n2hpg3 |
Similar Items
-
Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients
by: Valderilio Feijó Azevedo, et al.
Published: (2014-01-01) -
Benzbromarone in the treatment of gout
by: Valderilio Feijó Azevedo, et al.
Published: (2019-08-01) -
Evaluation of the clinical dose and effectiveness of allopurinol and benzbromarone on hyperuricemia in patients with different renal function
by: Pei-Fen Chuang, et al.
Published: (2008) -
Gout and allopurinol use in heart failure
by: Thanassoulis, George
Published: (2011) -
A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
by: Shih-Wei Lai, et al.
Published: (2021-09-01)